This study detected ten shared key genes (CDC42, SCARB1, GOT2, CXCL8, FN1, IL1B, JUN, TLR2, TLR4, and VIM) that are able to differentiate both T2D and ccRCC patients from the control groups. This evidence concerns the gene VIM and nonpapillary renal cell carcinoma.